Avista Healthcare
Skillman, NJ, January 2, 2014 – 180 Medical, a leader in the home delivery of intermittent catheters and other medical supplies, announced today that it has acquired Symbius Medical, a national home medical supply company. “Symbius and 180 Medical share a common focus on providing exceptional customer care in the home delivery of medical supplies,” […]
New York, NY, and Sayreville, NJ, December 16, 2013 – Avista Capital Partners (“Avista”), a leading private equity firm, and Vertical / Trigen Holdings (“Vertical / Trigen” or “the Company”), which owns Vertical Pharmaceuticals and Trigen Laboratories, today announced that Avista has acquired a controlling equity interest in Vertical / Trigen. Avista is partnering with […]
Escondido, CA, and New York, NY, July 2, 2013 – Avista Capital Partners (“Avista”), a leading private equity firm, and ZEST Anchors, Inc. (“Zest” or “the Company”) have signed a definitive agreement under which Avista will acquire Zest from The Jordan Company. Zest is a leading global designer and manufacturer of LOCATOR® branded overdenture abutment […]
Skillman, NJ – September 28, 2012 – ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has completed the acquisition of 180 Medical Holdings, Inc. (“180 Medical”). 180 Medical is a leader in the home delivery of disposable, intermittent catheters and urologic medical supplies in the […]
New York, NY, Sept. 10, 2012 – Avista Capital Partners today announced that Brian A. Markison has joined the firm as a healthcare Industry Executive. Mr. Markison has more than 30 years of experience in the pharmaceuticals sector, most recently as President and Chief Executive Officer of Fougera Pharmaceuticals, a dermatology-focused pharmaceuticals company that was […]
Chatsworth, California; Baar-Zug, Switzerland; New York, New York, September 6, 2012 – Strategic Partners’ management team, Partners Group, the global private markets investment manager, and Avista Capital Partners (“Avista”), a leading private equity firm, today announced they have closed on the acquisition of Strategic Partners, Inc. (“Strategic Partners”). Strategic Partners is a leader in the […]
Skillman, NJ – August 31, 2012 – ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has entered into a definitive agreement to acquire all of the capital stock of 180 Medical Holdings, Inc. (“180 Medical”) for $321 million. 180 Medical is a leading U.S. provider […]
May 2, 2012 – A consortium of private equity funds led by Nordic Capital Funds V and VI (”Nordic Capital”), including DLJ Merchant Banking Partners (a Credit Suisse affiliate) and Avista Capital Partners, today announced a definitive agreement to sell Fougera Pharmaceuticals Inc. (“Fougera” or “the Company”) to Sandoz, the generics division of Novartis, at […]
London, UK – March 2, 2012 – ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care today announced that Amcare Ltd, a wholly-owned subsidiary of ConvaTec Holdings UK Ltd, has acquired SureCalm Healthcare Holdings Ltd and subsidiaries (“SureCalm Healthcare”), a UK-based homecare services group that specialises in the home […]
Raleigh, N.C., Feb. 29, 2012 – INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the Company has received the “most consistent service quality ratings of all the companies profiled” in the 2012 CRO Quality Benchmarking Report published by Industry Standard Research (ISR). For […]
Increases Scale in Vascular Access and Peripheral Vascular Markets Expands Product Portfolio and Adds Innovative Technologies Strengthens Focus on Operational Excellence Expected to be Accretive in FY13 ALBANY, N.Y. and MARLBOROUGH, Mass., Jan. 31, 2012 – (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral […]
Rockville, MD, USA – January 9, 2012 – BioReliance, a leading provider of global biopharmaceutical testing services, announced today that it has agreed to be acquired by Sigma-Aldrich Corporation (NASDAQ:SIAL). Avista Capital Partners, the majority owner of BioReliance Holdings, Inc., agreed to sell the company for $350 million in cash. The acquisition is subject to […]